Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

被引：417

作者：

Reul, JMHM ^{[1
]}

Holsboer, F ^{[1
]}

机构：

[1] Max Planck Inst Psychiat, D-80804 Munich, Germany

来源：

CURRENT OPINION IN PHARMACOLOGY | 2002年 / 2卷 / 01期

关键词：

D O I：

10.1016/S1471-4892(01)00117-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Corticotropin-releasing factor (CRF) and its related family members are implicated in stress-related disorders such as anxiety and depression. Recently, two new members of this neuropeptide family have been discovered in the brain: urocortin 11 (also known as stresscopin-related peptide) and urocortin III (also known as stresscopin). These urocortins are selective agonists for the CRF2 receptor, show a distinct neuroanatomical localization and are involved in stress-coping responses such as anxiolysis. Thus, CRF the urocortins and their receptors form an intricate network in the brain involved in the acute phase as well as the recovery phase of the stress response.

引用

页码：23 / 33

页数：11

共 85 条

[1]

AMSTERDAM JD, 1987, ARCH GEN PSYCHIAT, V44, P775

[2] Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress [J].